Who
Kristiina Vuori
Director
Company insider
Files Form 4 as: Director, Inhibrx Biosciences; Director, Forian; Director, Bionano Genomics; Director, Inhibrx; Director, Sio Gene Therapies; Director, WebMD Health.
In numbers
- Trades disclosed
- 61
- Buys
- 4
- Sells
- 1
- Bought
- $300K
- Sold
- $83K
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 7 Jul 2014
- Last trade
- 3 Jun 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 18 Sep 2026 | INBX Inhibrx Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 3 Jun 2026filed 18 Sep 2026 | INBX Inhibrx Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | INBX Inhibrx Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | INBX Inhibrx Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 15 May 2026filed 15 May 2026 | ForianPayments & Processors | SEC FORM 4 Code U | —28,757 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative · Payments & Processors | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative · Payments & Processors | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative · Payments & Processors | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative · Payments & Processors | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forianoption or derivative · Payments & Processors | SEC FORM 4 Code D | —15,000 | filing |
| 15 May 2026filed 15 May 2026 | Forian | SEC FORM 4 Code U | —28,757 | filing |
| 14 May 2026filed 14 May 2026 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —9,149 at $0.00 | filing |
| 14 May 2026filed 14 May 2026 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —9,149 at $0.00 | filing |
| 11 Jun 2025filed 12 Jun 2025 | BNGO Bionano Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,775 at $0.00 | filing |
| 28 May 2025filed 29 May 2025 | INBX Inhibrx Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
Insider Buying: Inhibrx Biosciences (NASDAQ:INBX) CEO Acquires $848,982.40 in StockINBX · themarketsdaily.com · 17 Oct 2026Inhibrx Biosciences (NASDAQ:INBX) CEO Purchases $848,982.40 in StockINBX · dailypolitical.com · 15 Oct 2026Connect Biopharma (NASDAQ:CNTB) and Inhibrx Biosciences (NASDAQ:INBX) Financial ReviewINBX · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Kristiina Vuori; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.